Long-term results for Stage IIIB cervical cancer patients receiving external beam radiotherapy combined with either HDR 252Cf or HDR 60Co intracavitary brachytherapy

Applying 252Cf ICBT with EBRT was effective for International Federation of Gynecology and Obstetrics IIIB cervical cancer patients. Moreover, long-term followup data demonstrated higher survival rates in patients treated with 252Cf ICBT than 60Co ICBT. Complications in patients treated with neutron ICBT were not more frequent or severe than those treated with 60Co ICBT.